Cor Vasa 2003, 44(10):517-519

Impact of acebutolol on claudications, Doppler data and quality of life in patients with peripheral arterial obstructive disease

Petra Mašková*, Jan Lukl, Pavel Marcián, Ladislav Luběna
I. interní klinika, Fakultní nemocnice, Olomouc, Česká republika

Beta-blockers are not widely recommended in patients with peripheral artery disease although many patients could possibly benefit from beta-blocker use because of concomitant diseases. The aim of the study was to determine whether or not acebutolol therapy would deteriorate claudications, Doppler data, and quality of life in patients with peripheral artery disease. None of the above parameters was significantly deteriorated by acebutolol compared to placebo in 21 patients.

Keywords: Peripheral artery disease; Acebutolol; Doppler data; Claudications; Quality of life

Published: October 1, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mašková P, Lukl J, Marcián P, Luběna L. Impact of acebutolol on claudications, Doppler data and quality of life in patients with peripheral arterial obstructive disease. Cor Vasa. 2003;44(10):517-519.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)

    • Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes